The global in vitro fertilization (IVF) market is witnessing robust growth, with revenues estimated at $638 million in 2021 and a projected increase to $987 million by 2026, representing a remarkable CAGR of 9.1%. This expansion is driven by a variety of factors, including the rising median age of first-time mothers, greater public awareness of infertility, and the availability of IVF treatment options. However, challenges such as the high cost of IVF procedures and ethical concerns still pose constraints on the market’s growth.
Download PDF Brochure-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89198891
Growth in Median Age of First-Time Mothers: The global trend of women delaying childbirth due to pursuing higher education, career opportunities, and changing societal norms has led to a higher median age of first-time mothers. As couples opt for fertility treatments, the demand for IVF services is on the rise, making this trend a significant driver of the IVF market’s growth.
High Costs Associated with IVF Procedures: IVF is a costly procedure that often lacks insurance coverage. The average cost per IVF cycle, ranging from $10,000 to $15,000, coupled with the expenses of medications, can be a significant deterrent for many couples considering IVF. High costs remain a key challenge in expanding the adoption of IVF.
Increasing Medical Tourism in Emerging Nations: Medical tourism is on the rise, with patients from developing countries seeking better healthcare services abroad. IVF has gained popularity among couples in emerging economies, and the trend of medical tourism is expected to fuel the market’s growth further. Increased awareness of fertility treatments and the establishment of infertility clinics and hospitals contribute to this opportunity.
Reducing Efficacy of Infertility Treatment with Advancing Age: IVF effectiveness tends to decrease with age, primarily due to declining egg and sperm quality. Developing methods to enhance IVF effectiveness in older patients is a challenge. Techniques like assisted hatching and intracytoplasmic sperm injection (ICSI) may offer solutions by focusing on improving embryo quality and selection.
- Product: The equipment segment is expected to experience the highest growth rate during the forecast period, driven by increasing IVF procedures and the introduction of sophisticated equipment.
- Cycle: The fresh non-donor IVF cycle is the largest market participant, benefiting from high success rates and simplicity.
- Type: IVF with ICSI shows the highest growth rate, driven by its effectiveness in fertilization.
- End User: Fertility clinics lead the market, with rising government initiatives and international healthcare providers establishing fertility centers.
Asia Pacific: This region controls the IVF market due to factors such as medical tourism, increasing awareness of IVF treatments, expansion of fertility clinics, and the use of assisted reproductive technology in developing countries.
Prominent players in the IVF market include Cooper Companies Inc., Cook Group, Vitrolife, Thermo Fisher Scientific, Esco Micro, Genea Limited, IVFtech, FUJIFILM Irvine Scientific, The Baker Company, Kitazato Corporation, Rocket Medical plc, Hamilton Thorne Ltd., ZEISS Group, FERTIPRO NV, and Gynotec B.V.
The global IVF market is on an upward trajectory, driven by changing demographics and growing awareness of fertility treatments. While high costs remain a challenge, opportunities in medical tourism and technological advancements offer promising prospects for market growth. As IVF procedures become more accessible and affordable, the market is set to expand further, particularly in emerging economies.